NDC 0002-1460 – Mounjaro
Tirzepatide 12.5 mg/.5mL · Injection, Solution · Subcutaneous
Product NDC0002-1460
Product details
- Brand name
- Mounjaro
- Generic name
- tirzepatide
- Labeler
- Eli Lilly and Company
- Dosage form
- Injection, Solution
- Route
- Subcutaneous
- Marketing category
- NDA · NDA215866
- Marketed since
- May 13, 2022
- Listing expires
- December 31, 2027
- Pharmacologic class
- GLP-1 Receptor Agonist; Glucose-dependent Insulinotropic Polypeptide Receptor Agonist
Active ingredients
- Tirzepatide 12.5 mg/.5mL
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 0002-1460-80 | 4 SYRINGE in 1 CARTON (0002-1460-80) / .5 mL in 1 SYRINGE (0002-1460-01) | May 13, 2022 |
Other Mounjaro products
- 50090-8024 Tirzepatide 5 mg/.5mL · Injection, Solution · A-S Medication Solutions
- 50090-8025 Tirzepatide 2.5 mg/.5mL · Injection, Solution · A-S Medication Solutions
- 50090-8023 Tirzepatide 7.5 mg/.5mL · Injection, Solution · A-S Medication Solutions
- 50090-8026 Tirzepatide 15 mg/.5mL · Injection, Solution · A-S Medication Solutions
- 50090-8022 Tirzepatide 12.5 mg/.5mL · Injection, Solution · A-S Medication Solutions
- 50090-8021 Tirzepatide 10 mg/.5mL · Injection, Solution · A-S Medication Solutions
- 0002-1243 Tirzepatide 5 mg/.5mL · Injection, Solution · Eli Lilly and Company
- 0002-1457 Tirzepatide 15 mg/.5mL · Injection, Solution · Eli Lilly and Company
- 0002-1484 Tirzepatide 7.5 mg/.5mL · Injection, Solution · Eli Lilly and Company
- 0002-1495 Tirzepatide 5 mg/.5mL · Injection, Solution · Eli Lilly and Company
- 0002-2214 Tirzepatide 7.5 mg/.5mL · Injection, Solution · Eli Lilly and Company
- 0002-3002 Tirzepatide 15 mg/.5mL · Injection, Solution · Eli Lilly and Company